5200 ILLUMINA WAY, SAN DIEGO, CA
Reports Financial Results for Second Quarter of Fiscal Year 2025
To acquire SomaLogic, accelerating its proteomics business and advancing the multiomics strategy
News, Material Contracts
Earnings Release
Annual Report to Security Holders
Board of Directors Elects Dr. Scott Gottlieb Chair, Keith Meister to Join Board of Directors
Changes in Board, Management or Compensation
Addresses recent developments in China
Q2
Q1
FY 2023
Q3
Prospectus Filed Pursuant to Rule 424(b)(2)
S-3ASR
Registration Statement for Securities to be Offered to Employees
SC TO-I
Prospectus Filed Pursuant to Rule 425
Additional Proxy Materials
Definitive Proxy Statement
Definitive Additional Information Statement
Statement of Changes in Beneficial Ownership
Specialized Disclosure Report
Definitive Revised Proxy Statement
Free Writing Prospectus
Submission Upload